全文获取类型
收费全文 | 61378篇 |
免费 | 6959篇 |
国内免费 | 4598篇 |
专业分类
耳鼻咽喉 | 490篇 |
儿科学 | 612篇 |
妇产科学 | 604篇 |
基础医学 | 7358篇 |
口腔科学 | 1206篇 |
临床医学 | 8062篇 |
内科学 | 9375篇 |
皮肤病学 | 614篇 |
神经病学 | 3482篇 |
特种医学 | 2257篇 |
外国民族医学 | 52篇 |
外科学 | 6310篇 |
综合类 | 11040篇 |
现状与发展 | 19篇 |
一般理论 | 5篇 |
预防医学 | 4217篇 |
眼科学 | 1853篇 |
药学 | 6836篇 |
37篇 | |
中国医学 | 3424篇 |
肿瘤学 | 5082篇 |
出版年
2024年 | 90篇 |
2023年 | 1065篇 |
2022年 | 1476篇 |
2021年 | 2991篇 |
2020年 | 2586篇 |
2019年 | 2242篇 |
2018年 | 2260篇 |
2017年 | 2095篇 |
2016年 | 1982篇 |
2015年 | 2986篇 |
2014年 | 3707篇 |
2013年 | 3168篇 |
2012年 | 4933篇 |
2011年 | 5319篇 |
2010年 | 3146篇 |
2009年 | 2436篇 |
2008年 | 3366篇 |
2007年 | 3242篇 |
2006年 | 3179篇 |
2005年 | 3128篇 |
2004年 | 2049篇 |
2003年 | 1985篇 |
2002年 | 1629篇 |
2001年 | 1387篇 |
2000年 | 1428篇 |
1999年 | 1632篇 |
1998年 | 989篇 |
1997年 | 946篇 |
1996年 | 685篇 |
1995年 | 644篇 |
1994年 | 643篇 |
1993年 | 394篇 |
1992年 | 563篇 |
1991年 | 427篇 |
1990年 | 390篇 |
1989年 | 326篇 |
1988年 | 317篇 |
1987年 | 252篇 |
1986年 | 218篇 |
1985年 | 181篇 |
1984年 | 99篇 |
1983年 | 60篇 |
1982年 | 45篇 |
1981年 | 41篇 |
1980年 | 19篇 |
1979年 | 42篇 |
1978年 | 15篇 |
1977年 | 14篇 |
1964年 | 7篇 |
1936年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
目的了解ICU护士预防呼吸机相关性肺炎集束化护理方案临床实施不佳的原因,为护理管理提供参考。方法采用质性研究的现象学方法,对在我中心ICU工作1年以上的19名护理人员进行深入访谈,按现象学研究方法整理分析资料。结果通过阅读、分析、反思、分类,提炼4个主题,包括病情限制不能实施相关护理、低学历低年资护士缺乏业务知识和临床经验、护理任务繁重而人员相对短缺的困扰、医嘱执行中的不规范问题。结论 ICU护士预防呼吸机相关性肺炎集束化护理方案实施不佳的主要原因有多方面,需引起护理管理者的重视,采取有效应对来促进护理质量持续改进。 相似文献
82.
83.
Qiang Fu Le Xu Yiwei Wang Qi Jiang Zheng Liu Junyu Zhang Quan Zhou Han Zeng Shanyou Tong Tao Wang Yangyang Qi Baoying Hu Hangcheng Fu Huyang Xie Lin Zhou Yuan Chang Yu Zhu Bo Dai Jiejie Xu 《European urology》2019,75(5):752-763
Background
Glutamine addiction is a hallmark of clear cell renal cell carcinoma (ccRCC); yet whether glutamine metabolism impacts local immune surveillance is unclear. This knowledge may yield novel immunotherapeutic opportunities.Objective
To seek a potential therapeutic target in glutamine-addicted ccRCC.Design, setting, and participants
Tumors from ccRCC patients from a Shanghai cohort and ccRCC tumor data from The Cancer Genome Atlas (TCGA) cohort were analyzed. In vivo and in vitro studies were conducted with fresh human ccRCC tumors and murine tumor cells.Outcome measurements and statistical analysis
Immune cell numbers and functions were analyzed by flow cytometry. Glutamine and cytokine concentrations were determined. Survival was compared between different subpopulations of patients using Kaplan-Meier and Cox regression analyses.Results and limitations
We found that in ccRCC, high interleukin (IL)-23 expression was significantly associated with poor survival in both TCGA (overall survival [OS] hazard ratio [HR] = 2.04, cancer-specific survival [CSS] HR = 2.95; all p < 0.001) and Shanghai (OS HR = 2.07, CSS HR = 3.92; all p < 0.001) cohorts. IL-23 blockade prolongs the survival of tumor-bearing mice, promotes T-cell cytotoxicity in in vitro cultures of human ccRCC tumors, and augments the therapeutic benefits of anti-PD-1 antibodies. Mechanistically, glutamine consumption by ccRCC tumor cells results in the local deprivation of extracellular glutamine, which induces IL-23 secretion by tumor-infiltrating macrophages via the activation of hypoxia-inducible factor 1α (HIF1α). IL-23 activates regulatory T-cell proliferation and promotes IL-10 and transforming growth factor β expression, thereby suppressing tumor cell killing by cytotoxic lymphocytes. The positive correlations between glutamine metabolism, IL-23 levels, and Treg responses are confirmed in both TCGA cohort and tumors from Shanghai ccRCC patients. Study limitations include the unclear impacts of glutamine deprivation and IL-23 on other immune cells.Conclusions
Macrophage-secreted IL-23 enhanced Treg functions in glutamine-addicted tumors; thus, IL-23 is a promising target for immunotherapy in ccRCC.Patient summary
In this study, we analyzed the immune components in glutamine-addicted clear cell renal cell carcinoma (ccRCC) tumors from two patient cohorts and conducted both in vitro and in vivo studies. We found that ccRCC tumor cell-intrinsic glutamine metabolism orchestrates immune evasion via interleukin (IL)-23, and IL-23–high patients had significantly poorer survival than IL-23–low patients. IL-23 should thus be considered a therapeutic target in ccRCC, either alone or in combination with immune checkpoint inhibitors. 相似文献84.
Xue Yao Yan Zhang Jian Hao Hui-Quan Duan Chen-Xi Zhao Chao Sun Bo Li Bao-You Fan Xu Wang Wen-Xiang Li Xuan-Hao Fu Yong Hu Chang Liu Xiao-Hong Kong Shi-Qing Feng 《中国神经再生研究》2019,(3)
Ferroptosis is an iron-dependent novel cell death pathway. Deferoxamine, a ferroptosis inhibitor, has been reported to promote spinal cord injury repair. It has yet to be clarified whether ferroptosis inhibition represents the mechanism of action of Deferoxamine on spinal cord injury recovery. A rat model of Deferoxamine at thoracic 10 segment was established using a modified Allen's method. Ninety 8-week-old female Wistar rats were used. Rats in the Deferoxamine group were intraperitoneally injected with 100 mg/kg Deferoxamine 30 minutes before injury. Simultaneously, the Sham and Deferoxamine groups served as controls. Drug administration was conducted for 7 consecutive days. The results were as follows:(1) Electron microscopy revealed shrunken mitochondria in the spinal cord injury group.(2) The Basso, Beattie and Bresnahan locomotor rating score showed that recovery of the hindlimb was remarkably better in the Deferoxamine group than in the spinal cord injury group.(3) The iron concentration was lower in the Deferoxamine group than in the spinal cord injury group after injury.(4) Western blot assay revealed that, compared with the spinal cord injury group, GPX4, xCT, and glutathione expression was markedly increased in the Deferoxamine group.(5) Real-time polymerase chain reaction revealed that, compared with the Deferoxamine group, mRNA levels of ferroptosis-related genes Acyl-CoA synthetase family member 2(ACSF2) and iron-responsive element-binding protein 2(IREB2) were up-regulated in the Deferoxamine group.(6) Deferoxamine increased survival of neurons and inhibited gliosis. These findings confirm that Deferoxamine can repair spinal cord injury by inhibiting ferroptosis. Targeting ferroptosis is therefore a promising therapeutic approach for spinal cord injury. 相似文献
85.
Feng Guan Wei-Cheng Peng Hui Huang Zu-Yuan Ren Zhen-Yu Wang Ji-Di Fu Ying-Bin Li Feng-Qi Cui Bin Dai Guang-Tong Zhu Zhi-Yong Xiao Bei-Bei Mao Zhi-Qiang Hu 《中国神经再生研究》2019,(12)
Cerebral ventricular infection(CVI) is one of the most dangerous complications in neurosurgery because of its high mortality and disability rates. Few studies have examined the application of neuroendoscopic surgical techniques(NESTs) to assess and treat CVI. This multicenter, retrospective study was conducted using clinical data of 32 patients with CVI who were assessed and treated by NESTs in China. The patients included 20 men and 12 women with a mean age of 42.97 years. NESTs were used to obliterate intraventricular debris and pus, fenestrate or incise the intraventricular compartment and reconstruct cerebrospinal fluid circulation, and remove artificial material. Intraventricular irrigation with antibiotic saline was applied after neuroendoscopic surgery(NES). Secondary hydrocephalus was treated by endoscopic third ventriculostomy or a ventriculoperitoneal shunt. Neuroendoscopic findings of CVI were used to classify patients into Grade I(n = 3), Grade II(n = 13), Grade III(n = 10), and Grade IV(n = 6) CVI. The three patients with grade I CVI underwent one NES,the 23 patients with grade II/III CVI underwent two NESs, and patients with grade IV CVI underwent two(n = 3) or three(n = 3) NESs.The imaging features and grades of neuroendoscopy results were positively related to the number of neurosurgical endoscopic procedures.Two patients died of multiple organ failure and the other 30 patients fully recovered. Among the 26 patients with secondary hydrocephalus,18 received ventriculoperitoneal shunt and 8 underwent endoscopic third ventriculostomy. There were no recurrences of CVI during the 6-to 76-month follow-up after NES. Application of NESTs is an innovative method to assess and treat CVI, and its neuroendoscopic classification provides an objective, comprehensive assessment of CVI. The study trial was approved by the Institutional Review Board of Beijing Shijitan Hospital, Capital Medical University, China. 相似文献
86.
87.
88.
89.